NO123574B - - Google Patents
Download PDFInfo
- Publication number
- NO123574B NO123574B NO4114/68A NO411468A NO123574B NO 123574 B NO123574 B NO 123574B NO 4114/68 A NO4114/68 A NO 4114/68A NO 411468 A NO411468 A NO 411468A NO 123574 B NO123574 B NO 123574B
- Authority
- NO
- Norway
- Prior art keywords
- group
- salts
- theoretical
- denotes
- xmax
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 10
- 125000001935 tetracenyl group Chemical class C1(=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C12)* 0.000 claims description 8
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 5
- -1 thiocarbamoyl group Chemical group 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 2
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 2
- 125000000542 sulfonic acid group Chemical group 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 235000019441 ethanol Nutrition 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000002211 ultraviolet spectrum Methods 0.000 description 5
- NAALWFYYHHJEFQ-ZASNTINBSA-N (2s,5r,6r)-6-[[(2r)-2-[[6-[4-[bis(2-hydroxyethyl)sulfamoyl]phenyl]-2-oxo-1h-pyridine-3-carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound N([C@@H](C(=O)N[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C=1C=CC(O)=CC=1)C(=O)C(C(N1)=O)=CC=C1C1=CC=C(S(=O)(=O)N(CCO)CCO)C=C1 NAALWFYYHHJEFQ-ZASNTINBSA-N 0.000 description 4
- 229960000975 daunorubicin Drugs 0.000 description 4
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 4
- 229960003109 daunorubicin hydrochloride Drugs 0.000 description 4
- 239000002198 insoluble material Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 208000007093 Leukemia L1210 Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BRWIZMBXBAOCCF-UHFFFAOYSA-N hydrazinecarbothioamide Chemical compound NNC(N)=S BRWIZMBXBAOCCF-UHFFFAOYSA-N 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 239000008176 lyophilized powder Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- YSULOORXQBDPCU-UHFFFAOYSA-N 2-(trimethylazaniumyl)ethanehydrazonate;hydrochloride Chemical compound [Cl-].C[N+](C)(C)CC(=O)NN YSULOORXQBDPCU-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N Theophylline Natural products O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- WARCRYXKINZHGQ-UHFFFAOYSA-N benzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1 WARCRYXKINZHGQ-UHFFFAOYSA-N 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 150000002485 inorganic esters Chemical class 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002895 organic esters Chemical class 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR124943 | 1967-10-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO123574B true NO123574B (fr) | 1971-12-13 |
Family
ID=8640288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO4114/68A NO123574B (fr) | 1967-10-18 | 1968-10-17 |
Country Status (16)
| Country | Link |
|---|---|
| AT (1) | AT282823B (fr) |
| BE (1) | BE722460A (fr) |
| BR (1) | BR6803181D0 (fr) |
| CH (1) | CH492697A (fr) |
| DE (1) | DE1803892A1 (fr) |
| DK (1) | DK128113B (fr) |
| ES (1) | ES359293A1 (fr) |
| FI (1) | FI49984C (fr) |
| FR (2) | FR1578722A (fr) |
| GB (1) | GB1212459A (fr) |
| IE (1) | IE32420B1 (fr) |
| IL (1) | IL30899A (fr) |
| NL (1) | NL147151B (fr) |
| NO (1) | NO123574B (fr) |
| SE (1) | SE340449B (fr) |
| YU (1) | YU33665B (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2007500A6 (fr) * | 1968-04-24 | 1970-01-09 | Farmaceutici Italia |
-
1967
- 1967-10-18 FR FR124943A patent/FR1578722A/fr not_active Expired
-
1968
- 1968-01-15 FR FR136038A patent/FR7123M/fr not_active Expired
- 1968-09-19 FI FI682648A patent/FI49984C/fi active
- 1968-10-11 NL NL686814582A patent/NL147151B/xx unknown
- 1968-10-16 BR BR203181/68A patent/BR6803181D0/pt unknown
- 1968-10-17 GB GB49280/68A patent/GB1212459A/en not_active Expired
- 1968-10-17 DK DK501468AA patent/DK128113B/da unknown
- 1968-10-17 NO NO4114/68A patent/NO123574B/no unknown
- 1968-10-17 BE BE722460D patent/BE722460A/xx unknown
- 1968-10-17 SE SE14021/68A patent/SE340449B/xx unknown
- 1968-10-17 CH CH1554168A patent/CH492697A/fr not_active IP Right Cessation
- 1968-10-17 IE IE1233/68A patent/IE32420B1/xx unknown
- 1968-10-18 DE DE19681803892 patent/DE1803892A1/de active Pending
- 1968-10-18 IL IL30899A patent/IL30899A/xx unknown
- 1968-10-18 AT AT1019468A patent/AT282823B/de not_active IP Right Cessation
- 1968-10-18 YU YU2436/68A patent/YU33665B/xx unknown
- 1968-10-18 ES ES359293A patent/ES359293A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BR6803181D0 (pt) | 1973-02-22 |
| FR1578722A (fr) | 1969-08-22 |
| ES359293A1 (es) | 1970-06-01 |
| AT282823B (de) | 1970-07-10 |
| SE340449B (fr) | 1971-11-22 |
| FI49984C (fi) | 1975-11-10 |
| FI49984B (fr) | 1975-07-31 |
| YU33665B (en) | 1977-12-31 |
| IE32420B1 (en) | 1973-07-25 |
| DK128113B (da) | 1974-03-04 |
| GB1212459A (en) | 1970-11-18 |
| IL30899A (en) | 1972-11-28 |
| YU243668A (en) | 1977-06-30 |
| NL147151B (nl) | 1975-09-15 |
| FR7123M (fr) | 1969-07-21 |
| IL30899A0 (en) | 1968-12-26 |
| BE722460A (fr) | 1969-04-17 |
| CH492697A (fr) | 1970-06-30 |
| DE1803892A1 (de) | 1969-05-29 |
| NL6814582A (fr) | 1969-04-22 |
| IE32420L (en) | 1969-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3218324A (en) | 1-methyl ergotamines and ergocornines | |
| WO2006018222A1 (fr) | Nouveaux hydrates et polymorphes du 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl)-benzamide, son procede de production et son utilisation comme medicament | |
| EP0101574B1 (fr) | 1-aminoalkyl-1,2,3,4-tétrahydro-beta-carbolines, leur préparation et leur utilisation comme médicaments | |
| LV10868B (en) | Oxadiazolyl-alkyl-purine derivatives | |
| EP1261609B1 (fr) | Triazolotriazinones et leur utilisation | |
| NO125675B (fr) | ||
| DE2804519C2 (fr) | ||
| DE2724501A1 (de) | Neue, in 11-stellung substituierte 5,11-dihydro-6h-pyrido eckige klammer auf 2,3-b eckige klammer zu eckige klammer auf 1,4 eckige klammer zu benzodiazepin-6- one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| DE19816857A1 (de) | Neue unsymmetrisch substituierte Xanthin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| EP0464927B1 (fr) | 2-Hydroxy-1,2,3-propane-tricarboxylate de 3-[(5-méthyl-2-furanyl)méthyl]-N-(4-pipéridinyl)-3H-imidazo[4,5-b]-pyridine-2-amine | |
| NO123574B (fr) | ||
| EP0621037A1 (fr) | Composés pyrido-pyrimidinediones, leur préparation et leur utilisation pharmaceutique | |
| GB2081708A (en) | Novel derivatives of (1-benzyl-1h-indazol-3-yl) oxyacetic acid and pharmaceutical composition containing it | |
| NO138026B (no) | Analogifremgangsm}te til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner | |
| US3583992A (en) | 1-methyl-d-lysergic acid-dihydroxy-alkyl-amides | |
| US2734062A (en) | Method of making them | |
| DE2238923A1 (de) | Acylierte n(6)-aralkyl-adenosinderivate und verfahren zur herstellung derselben | |
| DE3017560A1 (de) | 9-amino-6,7-dihydro-4h-pyrido eckige klammer auf 1,2-a eckige klammer zu pyrimidin-4-on-derivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische kompositionen | |
| US4010265A (en) | 8-Alkylpyrido[3,4-d]pyridazines | |
| US3015658A (en) | Process for the preparation of new | |
| CH590278A5 (fr) | ||
| US3144457A (en) | Nu-(2-phthalimidoethyl) quaternary ammonium salts of triethylenediamine | |
| US4148898A (en) | N-oxy-ajmaline and the use thereof in treating cardiovascular disorders | |
| KR790001260B1 (ko) | 크산틴 유도체의 제조방법 | |
| US3519644A (en) | Azabicycloalkane derivatives |